1-9 of 9
Wei Peng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Dose Escalation Phase Ia Study of Anti-CD20 Antibody Drug Conjugate, MRG001 in Relapsed/Refractory Advanced Non-Hodgkin Lymphom

Yuqin Song, Ye Guo, Zhao Wang, Meng Wu, Wei Peng, Lei Sun, Jinghui Sun, Maggie Li, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2490.
https://doi.org/10.1182/blood-2021-144829
Published: 2021
Journal Articles

Disease and Clinical Characteristics of Patients with Polycythemia Vera: An Early View of the Reveal Study

Brady Stein, MD, Alison Moliterno, MD, Ralph V. Boccia, MD, Ahmad B. Naim, MD, Joseph A. Cordaro, PharmD,MBA, Wei Peng, PhD, Hao Sun, MS, Shreekant V. Parasuraman, PhD, Ruben A. Mesa
Journal: Blood
Blood (2015) 126 (23): 2813.
https://doi.org/10.1182/blood.V126.23.2813.2813
Published: 2015
Journal Articles

Burden of Phlebotomy in Patients with Polycythemia Vera in the United States: Baseline Data from the REVEAL Study

Ralph V. Boccia, MD, Brady Stein, MD, Ruben A. Mesa, Ahmad B. Naim, MD, Joseph A. Cordaro, PharmD,MBA, Wei Peng, PhD, Hao Sun, MS, Shreekant V. Parasuraman, PhD, Alison Moliterno, MD
Journal: Blood
Blood (2015) 126 (23): 5187.
https://doi.org/10.1182/blood.V126.23.5187.5187
Published: 2015
Journal Articles

Self-Reported Quality-of-Life Impairment and Productivity Loss in Patients with Polycythemia Vera: Early Patient-Reported Outcomes Assessment from the REVEAL Study

Ruben A. Mesa, Ralph V. Boccia, MD, Alison Moliterno, MD, Ahmad B. Naim, MD, Joseph A. Cordaro, PharmD,MBA, Wei Peng, PhD, Hao Sun, MS, Shreekant V. Parasuraman, PhD, Brady Stein, MD
Journal: Blood
Blood (2015) 126 (23): 4084.
https://doi.org/10.1182/blood.V126.23.4084.4084
Published: 2015
Journal Articles

The Impact of Anemia on Overall Survival in Patients with Myelofibrosis Treated with Ruxolitinib: An Exploratory Analysis of the Comfort Studies

Vikas Gupta, MD FRCP, FRCPath, Claire N. Harrison, Elizabeth O. Hexner, MD, Haifa Kathrin Al-Ali, MD, Lynda Foltz, MD FRCP, Michael Montgomery, MD, Wei Peng, PhD, Prashanth Gopalakrishna, MBBS, MRCS, Hagop Kantarjian, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1604.
https://doi.org/10.1182/blood.V126.23.1604.1604
Published: 2015
Journal Articles

A Pooled Overall Survival Analysis of The COMFORT Studies: 2 Randomized Phase 3 Trials of Ruxolitinib For The Treatment of Myelofibrosis

Alessandro M. Vannucchi, MD, Kantarjian Hagop, Jean-Jacques Kiladjian, MD, PhD, Jason Gotlib, MD, MS, Francisco Cervantes, MD, PhD, Ruben A. Mesa, MD, Giovanni Barosi, MD, Nicholas Sarlis, Wei Peng, PhD, Victor A. Sandor, MD, CM, Andres Sirulnik, MD, PhD, Abdel Hmissi, Viktoriya Stalbovskaya, PhD, Vikas Gupta, MD, FRCP, FRCPath, Claire N Harrison, DM, FRCP, FRCPath, Srdan Verstovsek, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2820.
https://doi.org/10.1182/blood.V122.21.2820.2820
Published: 2013
Journal Articles

Long-Term Outcomes Of Ruxolitinib Therapy In Patients With Myelofibrosis: 3-Year Update From COMFORT-I

Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. Dipersio, MD, PhD, John V. Catalano, MD, Michael W. Deininger, MD, PhD, Carole B. Miller, MD, Richard T. Silver, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Roger M. Lyons, MD, Ronald Paquette, MD, Azra Raza, MD, Kris Vaddi, PhD, William Sun, PhD, Wei Peng, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2013) 122 (21): 396.
https://doi.org/10.1182/blood.V122.21.396.396
Published: 2013
Journal Articles

Efficacy, Hematologic Effects, and Dose of Ruxolitinib in Myelofibrosis Patients with Low Starting Platelet Counts (50–100 × 10 9 /L): A Comparison to Patients with Normal or High Starting Platelet Counts

Moshe Talpaz, MD, Ronald Paquette, MD, PhD, Lawrence Afrin, MD, Solomon Hamburg, MD, PhD, Katarzyna Jamieson, MD, Howard Terebelo, DO, Gregory Ortega, MD, Roger M. Lyons, MD, Ramon V. Tiu, MD, BS, Elliott F. Winton, MD, Kavita Natrajan, MD, Olatoyosi Odenike, MD, Wei Peng, PhD, Victor A. Sandor, MD, CM, Peter O'Neill, MBA, CCRP, Sue Erickson-Viitanen, PhD, Lance Leopold, MD, Richard S Levy, MD, Hagop M Kantarjian, MD, Srdan Verstovsek, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 176.
https://doi.org/10.1182/blood.V120.21.176.176
Published: 2012
Journal Articles

Effect of Ruxolitinib On the Incidence of Splenectomy in Patients with Myelofibrosis: A Retrospective Analysis of Data From Ruxolitinib Clinical Trials.

Srdan Verstovsek, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Ruben A. Mesa, Alessandro M. Vannucchi, MD, Jason Gotlib, Giovanni Barosi, MD, Hagop M. Kantarjian, MD, Andres Sirulnik, MD, PhD, Wei Peng, PhD, Victor A. Sandor, MD, CM, Claire N Harrison, DM FRCP FRCPath
Journal: Blood
Blood (2012) 120 (21): 2847.
https://doi.org/10.1182/blood.V120.21.2847.2847
Published: 2012